Downloads: 1
Research Paper | Medical Science | Volume 15 Issue 4, April 2026 | Pages: 379 - 381 | India
Efficacy and Safety of Aspaghol (Plantago ovata Forssk.) in the Management of Warm-e-Unq-ur-Reham (Cervicitis): A Single-Blind Randomized Placebo-Controlled Trial
Abstract: Background: Cervicitis (Warm-e-Unq-ur-Reham) affects >50% of reproductive-age women globally, with an OPD incidence of 35-85%. Conventional antibiotic therapy is limited by resistance and recurrence. Aspaghol (Plantago ovata Forssk.), classified as Barid wa Ratab in Unani pharmacology, has classical indication in cervicitis owing to its Mohallil-e-Auram (anti-inflammatory) and Mulayyin (demulcent) properties. Methods: A single-blind, randomized, placebo-controlled trial was conducted on 44 women of reproductive age with clinically confirmed cervicitis (n=22 per group). The intervention group received Sufoof-e-Isapgol 5 g orally twice daily and intravaginal Humul (mucilage pessary) for 10 days per cycle over 3 consecutive menstrual cycles. Outcomes were assessed by symptom relief (white discharge, lower abdominal pain, backache) and per speculum findings (inflammation, hypertrophy, congestion). Statistical analysis used chi-square and Fisher's exact tests. Results: The intervention group showed highly significant improvement in white discharge (81.8%), lower abdominal pain (86.4%), and backache (77.3%), all p<0.001. Cervical inflammation resolved in 86.4% (p<0.001) and hypertrophy in 77.3% (p=0.017). The placebo group showed negligible improvement (?9.1%; p>0.05). No adverse effects were recorded. Conclusion: Aspaghol is a safe, effective, and cost-efficient Unani alternative for the management of cervicitis, demonstrating statistically significant superiority over placebo.
Keywords: Cervicitis, Warm-e-Unq-ur-Reham, Plantago ovata, Aspaghol, Unani Medicine, Randomized Controlled Trial, Intravaginal Pessary
How to Cite?: Dr. Dudekula Shafiya, Dr. A. Suhasini, "Efficacy and Safety of Aspaghol (Plantago ovata Forssk.) in the Management of Warm-e-Unq-ur-Reham (Cervicitis): A Single-Blind Randomized Placebo-Controlled Trial", Volume 15 Issue 4, April 2026, International Journal of Science and Research (IJSR), Pages: 379-381, https://www.ijsr.net/getabstract.php?paperid=SR26405184848, DOI: https://dx.dx.doi.org/10.21275/SR26405184848